Assisted living providers to face increased regulation from bill headed for governor’s signature
By
Kimberly Bonvissuto
Apr 08, 2024
A bill expected to become law and targeting assisted living reform in Arizona addresses some best practices long touted by industry experts, but it also brings an increase in regulations for providers.
Spotlight on smart lock highlights ways families, senior caregivers can keep those with dementia safe
By
Aaron Dorman
Sep 11, 2023
A smart lock for dementia highlights recent tech aimed at monitoring and keeping senior family members safe.
Increasing workforce, providing training top Alzheimer’s task force goals
By
Kimberly Bonvissuto
Jan 31, 2023
Increasing the workforce and providing dementia competency training are among the recommendations from a Missouri task force on Alzheimer’s care.
Biogen cuts price of controversial Aduhelm in half
Dec 21, 2021
The drug shows promise in clearing the brain plaques believed to play a role in Alzheimer’s disease.
RecallCue wins Gold for dementia clock
By
Foster Stubbs
Nov 11, 2022
Gold in the Tech Partner of the Year category of the 2022 McKnight’s Excellence in Technology Awards goes to RecallCue, an internet-connected day clock meant to combat the effects of dementia.
Medicare may rethink premium hike for pricey Alzheimer’s drug
Jan 10, 2022
The announcement comes shortly after Aduhelm maker Biogen cut the price of the drug by about half, from $56,000 to $28,000 a year.
App that completes sentences for dementia patients a big winner
By
Aaron Dorman
Jun 21, 2023
An Amicus Brain Innovations virtual speech assistant will utilize artificial intelligence to echo a “modified,” more cohesive version of a users’ impaired speech.
The importance of the life story in memory care
By
Beth Sanders
Dec 01, 2016
Knowing residents’ life stories is critical for staff members who care for those with Alzheimer’s disease or other memory or communication challenges.
Future of promising Alzheimer’s treatment Leqembi could depend on access to data reporting, analysis:...
By
Aaron Dorman
Feb 16, 2024
Organizations must have clearer guidelines as to how data on lecanemab will be collected, pooled and studied, policy experts say.
Lawmakers turn up heat on CMS to expand access to Alzheimer’s treatments
By
Kimberly Bonvissuto
Apr 28, 2023
Medicare needs to reconsider its national coverage decision on FDA-approved Alzheimer’s drug treatments, bipartisan members of the House told Centers for Medicare & Medicaid Services Administrator Chiquita...